(Q34594224)

English

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group (English)

1 reference

Europe PubMed Central

3 August 2017

multicenter clinical trial

0 references

mantle cell lymphoma

1 reference

based on heuristic

inferred from title

19

1 reference

Europe PubMed Central

3 August 2017

Elisabeth Ralfkiaer

14

object named as

Elisabeth Ralfkiaer

1 reference

Europe PubMed Central

3 August 2017

Marja-Liisa Karjalainen-Lindsberg

20

object named as

Marja-Liisa Karjalainen-Lindsberg

1 reference

Europe PubMed Central

3 August 2017

Nils Hermann Nilsson-Ehle

13

object named as

Herman Nilsson-Ehle

0 references

11

object named as

Outi Kuittinen

0 references

Christian Geisler

1

object named as

Christian H Geisler

1 reference

Europe PubMed Central

3 August 2017

Marie Nordström

8

object named as

Marie Nordström

1 reference

Europe PubMed Central

3 August 2017

2

object named as

Arne Kolstad

1 reference

Europe PubMed Central

3 August 2017

6

object named as

Mats Jerkeman

1 reference

Europe PubMed Central

3 August 2017

object named as

Eva Kimby

9

1 reference

ORCID Public Data File 2021

22

object named as

Erkki Elonen

1 reference

Europe PubMed Central

3 August 2017

16

object named as

Mats Ehinger

1 reference

Europe PubMed Central

3 August 2017

Nordic Lymphoma Group

23

object named as

Nordic Lymphoma Group

1 reference

Europe PubMed Central

3 August 2017

Mikael Eriksson

7

object named as

Mikael Eriksson

1 reference

Europe PubMed Central

3 August 2017

Anne Marie Boesen

10

object named as

Anne Marie Boesen

1 reference

Europe PubMed Central

3 August 2017

Grete Fossum Lauritzsen

12

object named as

Grete F Lauritzsen

1 reference

Europe PubMed Central

3 August 2017

Lone Bredo Pedersen

5

object named as

Lone B Pedersen

1 reference

Europe PubMed Central

3 August 2017

author name string

Anna Laurell

3

1 reference

Europe PubMed Central

3 August 2017

Niels S Andersen

4

1 reference

Europe PubMed Central

3 August 2017

Outi Kuittinen

11

1 reference

Europe PubMed Central

3 August 2017

Herman Nilsson-Ehle

13

1 reference

Europe PubMed Central

3 August 2017

Måns Akerman

15

1 reference

Europe PubMed Central

3 August 2017

Christer Sundström

17

1 reference

Europe PubMed Central

3 August 2017

Ruth Langholm

18

1 reference

Europe PubMed Central

3 August 2017

Peter Brown

21

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

14 July 2008

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

112

1 reference

Europe PubMed Central

3 August 2017

2687-2693

1 reference

Europe PubMed Central

3 August 2017

7

1 reference

Europe PubMed Central

3 August 2017

Controversies in lymphoma: the role of hematopoietic cell transplantation for mantle cell lymphoma and peripheral T cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

7 July 2018

Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

7 July 2018

Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

7 July 2018

High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

7 July 2018

Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

7 July 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

7 July 2018

Mantle cell lymphoma-- an entity comes of age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

7 July 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

7 July 2018

Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: the prognostic value of beta2-microglobulin and the tumor score

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1/JH rearrangements in mantle cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556606

27 October 2018

A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18625886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18625886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18625886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/18625886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18625886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory foll

1 reference

https://pubmed.ncbi.nlm.nih.gov/18625886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18625886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18625886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2008-03-147025

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34594224&oldid=2068353724"